Delivery Order SPE2DB22D3019-SPE2DB25FK3YF
Award Date 7/17/25
Potential Completion Date 7/18/25
Potential Value $17K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $8,582.36 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation. The contract is for the supply of MAVYRET 100-40 MG TABLET 84S, a pharmaceutical product, with a period of performance through April 8, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corporation is a major pharmaceutical distributor and healthcare solutions provider that plays a critical...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,719.72, is a delivery order for the supply of MAVYRET 100-40 MG TABLET 84S, a pharmaceutical product. The contract has an ultimate completion date of April 14, 2025 and is a firm fixed-price contract. This award is not associated with a set-aside program. AmerisourceBergen Drug Corp holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,232.50 firm fixed-price delivery order is for the supply of 4,568,173,815 units of the prescription medication MAVYRET 100-40 MG TABLET 84S. The contract has a performance period through May 8, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,363.99, is a delivery order for the supply of MAVYRET 100-40 MG TABLET 84S, a medical product. The contract has an ultimate completion date of February 12, 2025 and is a firm fixed-price arrangement. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,937.19 firm fixed-price contract is for the delivery of MAVYRET 100-40MG 84S, a pharmaceutical product, to support defense medical supply requirements. The contract has an ultimate completion date of May 16, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a...
- This federal contract award is for the delivery of MAVYRET 100-40 MG TABLET 84S, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $6,318.26 and is a Firm Fixed Price Delivery Order, awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is not set aside and is part of Amerisourcebergen Drug Corp's larger Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $40,954.16 firm fixed-price delivery order is for the supply of MAVYRET 100-40 MG TABLET 84S, a pharmaceutical product. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $19,836.92 firm fixed-price delivery order is for the supply of MAVYRET 100-40 MG TABLET 84S, a pharmaceutical product, with an ultimate completion date of October 17, 2023. The award is not associated with a set-aside program and appears to be part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical,...
- This is a $32,190.24 firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) on May 19, 2025. The contract has an ultimate completion date of May 20, 2025 and does not utilize any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor, and the award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- This is a $26,135.04 firm fixed price delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Medical Supply Chain. The contract has an ultimate completion date of July 18, 2025 and was competitively awarded without any set-aside designation. Amerisourcebergen Drug Corp, a for-profit organization, will provide a comprehensive range of pharmaceutical products and medical supplies to support federal medical...